NovoCure Limited logo

NovoCure Limited

NASDAQ:NVCR

Overview | Financials
Company Name NovoCure Limited
Symbol NVCR
Currency USD
Price 21.99
Market Cap 2,366,365,890
Dividend Yield 0%
52-week-range 10.87 - 83.47
Industry Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Asaf Danziger
Website https://www.novocure.com

An error occurred while fetching data.

About NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune

Related Stocks

Masimo Corporation logo

Masimo Corporation

MASI

124.1 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

142.29 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

28.28 USD

Repligen Corporation logo

Repligen Corporation

RGEN

171.94 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

50.38 USD

Bruker Corporation logo

Bruker Corporation

BRKR

75.07 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

11.32 USD

Acadia Healthcare Company, Inc. logo

Acadia Healthcare Company, Inc.

ACHC

66.35 USD

Financials

Numbers are in millions USD

Numbers are in millions USD